findmyKOL
Clinical trialNCT06699121RecruitingPhase 2Interventional

A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC

SponsorLISCure BiosciencesEnrollment87Primary Sclerosing Cholangitis (PSC)
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of California Davis

    Sacramento, California, United States

    Christopher Bowlus, MD
    Not, yet, recruiting
  • Uchealth University of Colorado Hospital

    Aurora, Colorado, United States

    Lisa Forman, MD
    Not, yet, recruiting
  • University of Iowa Hospitals and Clinics

    Iowa City, Iowa, United States

    Alan Gunderson, MD
    Recruiting
  • Mercy Medical Center

    Baltimore, Maryland, United States

    Paul Thuluvath, MD
    Recruiting
  • Mayo Clinic

    Rochester, Minnesota, United States

    John Eton, MD
    Not, yet, recruiting
  • the Vanderbilt Clinic

    Nashville, Tennessee, United States

    Manhal Izzy, MD
    Recruiting
  • Liver Institute Northwest

    Seattle, Washington, United States

    Kris Kowdley, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Nov 2025
Primary completion
31 Mar 2028
Completion
28 Feb 2029
Last update posted
24 Oct 2025
Registered enrollment
87
Registry id
NCT06699121

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.